Home

Dishman Carbogen Amcis Ltd PE Ratio

Image

Dishman Carbogen Amcis Ltd

NSE: DCAL

PE

-

Last updated on: Feb 21, 2025

Key Highlights

  • The P/E Ratio of Dishman Carbogen Amcis Ltd is 0 as of 21 Feb 11:33 AM .
  • The P/E Ratio of Dishman Carbogen Amcis Ltd changed from 5.3 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Latest Trading Price of Dishman Carbogen Amcis Ltd is ₹ 217.25 as of 21 Feb 11:23 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Dishman Carbogen Amcis Ltd

No data available

Company Fundamentals for Dishman Carbogen Amcis Ltd

Image

Dishman Carbogen Amcis Ltd

NSE: DCAL

Share Price

₹ 217.25

-3.95 (-1.79%)

stock direction

Last updated on: Feb 21, 2025

Market Price of Dishman Carbogen Amcis Ltd

1M

1Y

3Y

5Y

Monitoring Dishman Carbogen Amcis Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Feb 2025221.2
19 Feb 2025222.2
18 Feb 2025211.2
17 Feb 2025219.95
14 Feb 2025203.45
13 Feb 2025228.05
12 Feb 2025225.6
11 Feb 2025230.55
10 Feb 2025242.25
07 Feb 2025245.2

SWOT Analysis Of Dishman Carbogen Amcis Ltd

Strength

1

che

Weakness

3

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Dishman Carbogen Amcis Ltd

Asset Value vs Market Value of Dishman Carbogen Amcis Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Dishman Carbogen Amcis Ltd3468
Sun Pharmaceuticals Industries Ltd400617
Divis Laboratories Ltd158655
Cipla Ltd119511
Torrent Pharmaceuticals Ltd104729
Dr Reddys Laboratories Ltd97705

PE Ratio of Dishman Carbogen Amcis Ltd Explained

3468

Market cap

-109

Earnings

0.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Dishman Carbogen Amcis Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Dishman Carbogen Amcis Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Dishman Carbogen Amcis Ltd

No data available

* All values are in %

About Dishman Carbogen Amcis Ltd

  • Dishman Carbogen Amcis Limited was formerly incorporated as Carbogen Amcis (India) Limited on July 17, 2007.
  • The Company name later on was changed to Dishman Carbogen Amcis Limited effective from 27 March 2017.
  • The Company is engaged in Contract Research and Manufacturing Services (CRAMS) and manufacture and supply of marketable molecules such as specialty chemicals, vitamins & chemicals and disinfectants with presence in Switzerland, UK, Europe, China and other countries.
  • It has manufacturing and research facilities in India, Switzerland, France, The Netherland and China. During the financial year ended 31 March 2017, Dishman Pharmaceuticals and Chemicals Limited (DPCL) and Dishman Care Limited were merged with DPCL's subsidiary Carbogen Amcis (India) Limited, with the key objective of business consolidation and simplification of the Group structure.

Dishman Carbogen Amcis Ltd News Hub

Dishman Carbogen Amcis to conduct AGM

Dishman Carbogen Amcis announced that the 17th Annual General Meeting (AGM) of the company will be h

Read more

30 Aug 24

Dishman Carbogen slumps on dismal Q1 results

On a consolidated basis, Dishman Carbogen Amcis reported net loss of Rs 77.57 crore in Q1 June 2024

Read more

14 Aug 24

Dishman Carbogen Amcis Ltd leads losers in 'A' group

Piramal Enterprises Ltd, Redtape Ltd, Kaveri Seed Company Ltd and HEG Ltd are among the other losers

Read more

14 Aug 24

Dishman Carbogen Amcis reports consolidated net loss of Rs 77.57 crore in the June 2024 quarter

Net loss of Dishman Carbogen Amcis reported to Rs 77.57 crore in the quarter ended June 2024 as agai

Read more

14 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Dishman Carbogen Amcis Ltd

What is the current PE Ratio of Dishman Carbogen Amcis Ltd?

The Current PE Ratio of Dishman Carbogen Amcis Ltd is 0.0 as on 21 Feb 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 21 Feb 2025.

What was the PE Ratio of Dishman Carbogen Amcis Ltd last year?

The PE Ratio of Dishman Carbogen Amcis Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Dishman Carbogen Amcis Ltd indicate about its stock?

The PE Ratio of Dishman Carbogen Amcis Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Dishman Carbogen Amcis Ltd.

What is the PE Ratio Growth of Dishman Carbogen Amcis Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Dishman Carbogen Amcis Ltd grew by -% whereas, the EPS ratio grew by -85.8.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions